All In Biotech

Drug Trial Radar · NCT04250311

Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults

A Multicenter, Placebo-controlled, Double-blind, Randomized Clinical Trial in Parallel Groups to Evaluate the Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults

Last checked: Nov 19, 2026Latest source record: Aug 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

SuspendedPivotal-lookingPhase 3. Randomized with 314 participants. This is a heuristic, not a regulatory label.

Status

Suspended

Enrollment

314

Planned (sponsor's estimate)

Start

Dec 12, 2019

Primary completion

Dec 2024

Study completion Dec 2024

Sponsor

Lead sponsor
Materia Medica HoldingIndustry
Sponsor type
Industry
First posted
Jan 31, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is: • to evaluate the efficacy and safety of MMH-407 in the treatment of influenza in outpatient adults.

Conditions

  • Influenza

Interventions

  • MMH-407Drug

    MMH-407: For oral use.

  • PlaceboDrug

    Placebo: For oral use.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to improvement of influenza symptoms.Time frame: On days 1-14 of observation.

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • City Hospital # 5

    Barnaul, Russia

  • Belgorod State National Research University, Hospital Therapy Department

    Belgorod, Russia

  • Road Clinical Hospital at Chelyabinsk station of JSC Russian Railways

    Chelyabinsk, Russia

  • City Clinical Hospital # 9 of the Ministry of Health of the Udmurt Republic

    Izhevsk, Russia

  • Kazan State Medical University, Internal Medicine Department

    Kazan', Russia

  • Kuban State Medical University, Infectious Diseases and Phthisiopulmonology Department

    Krasnodar, Russia

  • Central Clinical Hospital of the Russian Academy of Sciences

    Moscow, Russia

  • City Clinical Hospital # 10 of the Kanavinsky District of Nizhny Novgorod

    Nizhny Novgorod, Russia

  • Road Clinical Hospital at the station Nizhny Novgorod of JSC Russian Railways

    Nizhny Novgorod, Russia

  • Vvedensky City Clinical Hospital

    Saint Petersburg, Russia

  • City Polyclinic # 25 of the Nevsky District

    Saint Petersburg, Russia

  • Medical Center "Reavita Med SPb"

    Saint Petersburg, Russia

  • Llc "Medical Clinic"

    Saint Petersburg, Russia

  • City Polyclinic # 43

    Saint Petersburg, Russia

  • Samara City Hospital # 4

    Samara, Russia

  • Scientific Medical Center for General Therapy and Pharmacology

    Stavropol, Russia

  • Tver State Medical University, Department of Hospital Therapy

    Tver', Russia

  • Bashkir State Medical University, Internal Medicine Department

    Ufa, Russia

  • Volgograd State Medical University

    Volgograd, Russia

  • Altai State Medical University, Department of Faculty Therapy with a course of immunology and allergology

    Barnaul, Moscow, Russia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.